Related Experiment Video

Updated: Aug 8, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

Molecular basis for the cellular senescence program and its application to anticancer therapy

Yoshinori Katakura1

  • 1Department of Genetic Resources Technology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan. katakura@grt.kyushu-u.ac.jp

Bioscience, Biotechnology, and Biochemistry
|May 24, 2006
PubMed

Insights

Transforming growth factor-beta (TGF-beta) induces cellular senescence in cancer cells, impairing their tumor growth. Mild oxidative stress also impacts cancer cell fate by affecting telomerase function.

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Cellular senescence, triggered by telomere dysfunction or stress, is a key process in normal cells but its molecular regulators are not fully understood.
  • Understanding the cellular senescence program is crucial for cancer research and therapeutic development.

Purpose of the Study:

  • To identify extrinsic factors that induce cellular senescence in cancer cells.
  • To elucidate the molecular mechanisms underlying cellular senescence.
  • To investigate the impact of oxidative stress on cancer cell fate.

Main Methods:

  • Screening of human lung adenocarcinoma cell line A549 for senescence-inducing factors.
  • Subtractive screening to identify senescence-associated genes.
  • Generation and characterization of novel cell lines (AST cells) from A549 cells exposed to oxidative stress.

Main Results:

  • Transforming growth factor-beta (TGF-beta) was identified as a potent inducer of cellular senescence in A549 cells, leading to impaired tumorigenicity in vitro and in vivo.
  • 86 senescence-associated genes were identified through subtractive screening.
  • AST cells exhibited impaired telomerase function due to altered subcellular localization of human telomerase reverse transcriptase, indicating a role for oxidative stress in cancer cell fate.

Conclusions:

  • Cellular senescence induced by TGF-beta acts as a tumor suppression mechanism.
  • The study provides insights into the molecular basis of cellular senescence and the impact of oxidative stress on cancer cell fate.
  • Further research into these pathways could lead to novel cancer therapies.

More Related Videos

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Techniques to Induce and Quantify Cellular Senescence06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...